Abion Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating industry group for Abion Inc are displayed below. The page contains a free Environmental, Social and Governance report for Abion Inc. The ESG rating covers seventeen United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Climate Action' and 'Life on Land'.
Abion Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Abion Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Abion Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Abion Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Abion Inc report the average age of the workforce?
Sign up for free to unlockDoes Abion Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Abion Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Abion Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Abion Inc offer flexible work?
Sign up for free to unlockDoes Abion Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Abion Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Abion Inc conduct supply chain audits?
Sign up for free to unlockDoes Abion Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Abion Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Abion Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Abion Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Abion Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Abion Inc disclose water use targets?
Sign up for free to unlockDoes Abion Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Abion Inc have a product recall in the last two years?
Sign up for free to unlockDoes Abion Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Abion Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Abion Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Abion Inc disclose parental leave metrics?
Sign up for free to unlockDoes Abion Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Abion Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Abion Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Abion Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Abion Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Abion Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Abion Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Abion Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Abion Inc disclose its waste policy?
Sign up for free to unlockDoes Abion Inc report according to TCFD requirements?
Sign up for free to unlockDoes Abion Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Abion Inc disclose energy use targets?
Sign up for free to unlockDoes Abion Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Abion Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Abion Inc
These potential risks are based on the size, segment and geographies of the company.
Abion Inc. engages in the development of chemical and biological drugs, and vaccines in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a drug candidate for lung and stomach cancer; ABN501, a biomarker for ovarian cancer; and ABN201, a fusion protein to target cancer cells. It also develops ABN101, an interferon-beta based biological drug for the treatment of autoimmune diseases in the central nervous system. In addition, the company is developing medical countermeasure vaccines, such as ABN701, a vaccine that protects against infection from staphylococcal enterotoxin B; and ABN601, a drug for the protection of immune system from acute radiation syndrome. Abion Inc. was founded in 2007 and is based in Seoul, South Korea.